Transchem Ltd
₹162.65
(1.02%)
Fri, 03 Apr 2026, 01:01 am
Transchem Ratios
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 22.12 | 18.61 | 5.96 | 0 | 0 | 0 | 0 | 0 | 0 | 221.50 | 437.50 | 0 | 0 | 95.30 | 48.57 | 0.85 | 9.39 | 18.71 | 8.17 | 7.80 |
| Price to book ratio | 0.35 | 0.58 | 0.43 | 0.15 | 0.35 | 0.41 | 0.49 | 0.79 | 0.73 | 0.71 | 0.56 | 0.72 | 1.08 | 0.77 | 0.54 | 0.32 | 0.41 | 0.35 | 0.45 | 0.51 |
| Price to sales ratio | 0.26 | 0.37 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.80 | 15.50 |
| Price to cash flow ratio | 5.02 | 0 | 1.54 | 0 | 0 | 0 | 15.74 | 14.73 | 35.84 | 19.18 | 15.82 | 33.51 | 0 | 2.57 | 0 | 0 | 1.23 | 18.71 | 0 | 1.13 |
| Enterprise value | 121.18M | 286.05M | 208.34M | 62.3M | 158.27M | 198.77M | -19.5M | 71.58M | 32.13M | 12.4M | -57.94M | -5.55M | 313.32M | 127.36M | 35.18M | 87.3M | -72.92M | -113.53M | 340.41M | -15.81M |
| Enterprise value to EBITDA ratio | 6.15 | 12.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.03 | 0.11 | 0 | 0 | 0 | 0.07 | 0.07 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 3.19 | 7.29 | -2.25 | -4.23 | -6.23 | -7.94 | -3.32 | -2.08 | 0.31 | 0.12 | -0.57 | -3.18 | 0.82 | 1.10 | 48.44 | 4.44 | 1.87 | 5.94 | 6.74 |
Transchem Ltd Ratios
The Transchem Ltd Ratios page provides a complete fundamental analysis of Transchem Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Transchem Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Transchem Ltd (NSE: TRANSCHEM, BSE: 500422) is currently trading at ₹162.65, with a market capitalization of ₹1.99B. As a major player in the Health technology sector and Pharmaceuticals: other industry, Transchem Ltd remains a key stock for fundamental analysis using Transchem Ltd Ratios.
Transchem Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Transchem Ltd P/E ratio currently stands at 7.80, making it one of the most tracked metrics in Transchem Ltd Ratios.
Historically, the Transchem Ltd P/E ratio has shown strong fluctuations:
- 2024: 7.80
- 2023: 8.17
- 2022: 18.71
- 2021: 9.39
- 2020: 0.85
The decline in Transchem Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Transchem Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.51.
Historical P/B trend:
- 2024: 0.51
- 2023: 0.45
- 2022: 0.35
- 2021: 0.41
Transchem Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Transchem Ltd P/S ratio currently stands at 15.50, an important part of Transchem Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 15.50
- 2023: 83.80
- 2022: 0
- 2021: 0
A stable or declining Transchem Ltd P/S ratio indicates cautious market sentiment.
Transchem Ltd Price to Cash Flow Ratio (P/CF)
The Transchem Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 1.13.
Historical Transchem Ltd Price to Cash Flow Ratio:
- 2024: 1.13
- 2023: 0
- 2022: 18.71
- 2021: 1.23
- 2020: 0
The rising Transchem Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Transchem Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Transchem Ltd EV currently stands at ₹-15.81M, representing the total company valuation including debt.
Historical EV trend:
- 2024: -15.81M
- 2023: 340.41M
- 2022: -113.53M
- 2021: -72.92M
Transchem Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Transchem Ltd EV/EBITDA ratio is currently 0, a key metric in Transchem Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
Stable Transchem Ltd EV/EBITDA indicates balanced valuation.
Transchem Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Transchem Ltd D/E ratio is currently 0, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
Transchem Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Transchem Ltd ROE currently stands at 6.74%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 6.74
- 2023: 5.94
- 2022: 1.87
- 2021: 4.44
Declining ROE indicates pressure on profitability.
Transchem Ltd Ratios Analysis Summary
The Transchem Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Transchem Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Transchem Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800